Navigation Links
Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
Date:12/1/2014

SAN DIEGO, Dec. 1, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced that Joseph E. Payne, President & CEO, will present at the 26th Annual Piper Jaffray Healthcare Conference being held on December 2-3 at New York Palace hotel in NY. The company presentation will take place on December 2nd, at 3:30 PM EST.

"We are pleased to provide a corporate overview highlighting the significant progress we have made with our leading UNA Oligomer™ chemistry and LUNAR™ delivery technologies, as well as our growing pipeline of RNA medicines," said Joseph E. Payne, President & CEO of Arcturus Therapeutics.

About Transthyretin (TTR)-Mediated Amyloidosis

Transthyretin (TTR)-mediated amyloidosis is a genetically mediated fatal disease caused by mutations in the TTR gene. Mutated TTR, which is mainly synthesized in the liver, causes errant amyloid proteins to aggregate and deposit, destroying body organs and tissue, such as the peripheral nerves and heart. TTR-mediated cardiomyopathy (FAC) affects approximately 40,000 people with the mean survival of ~2.5 years. TTR-mediated polyneuropathy (FAP) affects at least 10,000 people. There is a substantial unmet need for effective medicines for patients suffering from TTR-mediated diseases.

About Arcturus Therapeutics, Inc.

Founded in 2013 and based in San Diego, Arcturus Therapeutics is focused on RNA medicines for the treatment of rare diseases. Arcturus has developed a novel, potent and safe RNA Therapeutics platform called LUNAR™, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense RNA, and microRNA oligotherapeutics. The company's UNA Oligomer™ chemistry technology and patent portfolio (34 patents, USPTO granted) enables the targeting of any gene in the human genome. For more information, visit www.ArcturusRx.com.

Logo - http://photos.prnewswire.com/prnh/20130531/MM24393LOGO


'/>"/>
SOURCE Arcturus Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
2. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
3. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
9. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... 11, 2019 , ... Windsor Care Centers (Windsor) across California ... The Society of Corporate Compliance and Ethics & Health Care Compliance Association (SCCE ... 3 through 9, 2019. This is the third year Windsor participated. , Corporate ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... Over 60 ... new telehealth service in place. The program is designed to provide virtual mental health ... 5 storm that struck the region in October of 2018 [1]. , “This initiative ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... coordination and implementation of joint projects for the benefit of biomedical professionals ... empower biomedical professionals to leverage their roles in the research, development, and ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate Therapeutics, ... serious diseases, announced it will have 5 poster presentations related to its medical ... Society for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/12/2019)... Ind. (PRWEB) , ... November 12, 2019 , ... ... a select group of individuals/organizations who have truly impacted those diagnosed with infertility. ... received RESOLVE’s prestigious Hope Award for Achievement, presented at the Night of Hope ...
(Date:11/12/2019)... ... November 12, 2019 , ... Raintree Rehab, a division ... therapy and rehabilitation operators throughout the United States and Physitrack, an Apple Mobility ... today announces a joint venture to develop and market clinical outcomes data solutions. ...
(Date:11/11/2019)... NEW COLUMBIA, Pa. (PRWEB) , ... November 11, ... ... thermal processing equipment, announced the shipment of two (2) Gruenberg Depyrogenation Sterilizers ... equipment. , These pharmaceutical sterilizers have maximum temperature ratings of 280°C with work ...
(Date:11/11/2019)... ... 2019 , ... PracticeLink Live! Atlanta Physician Career Fair will take place Thursday, ... p.m. and continue until 8:00 p.m. A free, optional seminar for job-seeking physicians, residents ... p.m. , Both the career fair and seminar are open to residents and fellows, ...
Breaking Medicine News(10 mins):